Suresh K. Tipparaju

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Shichun Lun, Haidan Guo, Oluseye K. Onajole et al. · Nature Communications · 2013 · 151 citations · Full text

Pulmonary Tuberculosis, Health Sciences, Medicine +11

Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains

Oluseye K. Onajole, Marco Pieroni, Suresh K. Tipparaju et al. · Journal of Medicinal Chemistry · 2013 · 123 citations

In Pursuit of Natural Product Leads: Synthesis and Biological Evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4-carboxylic acid (A-33853) and Its Analogues: Discovery of <i>N</i>-(2-Benzoxazol-2-ylphenyl)benzamides as Novel Antileishmanial Chemotypes

Suresh K. Tipparaju, Sipak Joyasawal, Marco Pieroni et al. · Journal of Medicinal Chemistry · 2008 · 74 citations

Pyrido[1,2‐<i>a</i>]benzimidazole‐Based Agents Active Against Tuberculosis (TB), Multidrug‐Resistant (MDR) TB and Extensively Drug‐Resistant (XDR) TB

Marco Pieroni, Suresh K. Tipparaju, Shichun Lun et al. · ChemMedChem · 2011 · 65 citations · Full text

Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models

Walid S. Kamoun, Dmitri B. Kirpotin, Zhaohua Huang et al. · Nature Biomedical Engineering · 2019 · 57 citations

Nanomedicine, Drug Targeting, Nanotherapeutics +11